Financhill
Sell
32

IGC Quote, Financials, Valuation and Earnings

Last price:
$0.36
Seasonality move :
16.78%
Day range:
$0.33 - $0.38
52-week range:
$0.27 - $0.91
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
22.17x
P/B ratio:
3.98x
Volume:
728.3K
Avg. volume:
423.3K
1-year change:
28.04%
Market cap:
$29.4M
Revenue:
$1.3M
EPS (TTM):
-$0.18

Earnings Data

Next earnings date for IGC
Feb 14
2025
Most recent earnings per share
-$0.02
Beat by $0.01
(Nov 12/2024)
Consensus Estimate
-$0.03
(Nov 12/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

IGC Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/14/2025 Q4 $204K -- -- -$0.03 --
11/12/2024 Q3 $291K $412K -$0.02 -$0.03 $0.01
08/07/2024 Q2 $455.5K $272K -$0.03 -$0.03 --
03/31/2024 Q1 $193K $295K -$0.04 -$0.04 --
02/14/2024 Q4 $448K $204K -$0.09 -$0.04 -$0.05
11/13/2023 Q3 -- -- -$0.05 -- --
06/30/2023 Q2 -- -- -$0.04 -- --
03/31/2023 Q1 -- -- -$0.08 -- --
12/31/2022 Q4 -- -- -$0.04 -- --
09/30/2022 Q3 -- -- -$0.05 -- --
08/05/2022 Q2 -- -- -$0.05 -- --
03/31/2022 Q1 -- -- -$0.12 -- --
02/10/2022 Q4 -- -- -$0.05 -- --
10/29/2021 Q3 -- -- -$0.09 -- --
08/11/2021 Q2 -- -- -$0.04 -- --
03/31/2021 Q1 -- -- -$0.07 -- --
02/12/2021 Q4 -- -- -$0.06 -- --
11/20/2020 Q3 -- -- -$0.04 -- --
08/19/2020 Q2 -- -- -$0.05 -- --
03/31/2020 Q1 -- -- -$0.08 -- --
02/12/2020 Q4 -- -- -$0.04 -- --
11/06/2019 Q3 -- -- -$0.03 -- --
08/09/2019 Q2 -- -- -- -- --
06/17/2019 Q1 -- -- -- -- --
02/12/2019 Q4 -- -- -- -- --
10/16/2018 Q3 -- -- -- -- --
08/02/2018 Q2 -- -- -- -- --
06/21/2018 Q1 -- -- -- -- --
02/20/2018 Q4 -- -- -- -- --
11/20/2017 Q3 -- -- -- -- --
06/30/2017 Q2 -- -- -- -- --
03/31/2017 Q1 -- -- -- -- --
12/31/2016 Q4 -- -- -- -- --
09/30/2016 Q3 -- -- -- -- --
08/17/2016 Q2 -- -- -- -- --
03/31/2016 Q1 -- -- -- -- --
12/31/2015 Q4 -- -- -- -- --
09/30/2015 Q3 -- -- -- -- --
06/30/2015 Q2 -- -- -- -- --
03/31/2015 Q1 -- -- -- -- --
12/31/2014 Q4 -- -- -- -- --

IGC Pharma Earnings Questions

  • How Much did IGC Pharma Generate in Revenue Last Quarter?

    IGC Pharma reported $412K worth of top line sales in its most recent quarter.

  • Did IGC Pharma Beat Earnings Last Quarter?

    IGC Pharma announced earnings per share of -$0.02 which represents a beat of analyst forecast a -$0.03 per share.

  • Is IGC Pharma Profitable?

    IGC Pharma reported $198K that represents $0.00 per share over the last quarter.

  • What is the Analyst Consensus for IGC Pharma EPS Next Year?

    IGC Pharma's earnings are forecast to decrease from -$0.22 per share to -- per share next year representing a decrease of -40.91%.

  • When is IGC Pharma's Earnings Date?

    IGC Pharma's next earnings date is February 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock